Phase 1 trial of COVID-19 antibody drug begins
Phase 1 trial of COVID-19 antibody drug begins: US Pharma company Eli Lilly has started dosing participants in the Phase I clinical trial of antibody therapy to treat coronavirus. This is said to be the world’s first study to assess an antibody treatment for the disease.
Comments
Post a Comment